Educational reference only. Not medical advice. Nothing on this site is for sale.
Latest
Sign in

Hormonal & reproductive

Prostamax

Also called ProstaMax, KEDP peptide, Lys-Glu-Asp-Pro, prostate peptide bioregulator

Prostamax is a small lab-made peptide (four amino acids) from Vladimir Khavinson's Russian 'peptide bioregulator' series, named for the prostate. Online sellers promote it for enlarged prostate, but the published research is mainly lab work on chromosomes in blood cells. In June 2026 the FDA warned a US seller that Prostamax marketed with prostate claims is an unapproved new drug.

Preclinical onlyStudied in cells or animals only. Effects in people are unknown.

All printable flashcards

Drawn from its published sequence: 4 residues, one bead each.

Overview

Prostamax is a small lab-made peptide (four amino acids) from Vladimir Khavinson's Russian 'peptide bioregulator' series, named for the prostate. Online sellers promote it for enlarged prostate, but the published research is mainly lab work on chromosomes in blood cells. In June 2026 the FDA warned a US seller that Prostamax marketed with prostate claims is an unapproved new drug.

How it works

Proposed, not established. In cultured lymphocytes from elderly people, Prostamax loosened condensed chromatin, including structural heterochromatin near the centromere of chromosome 1, which the authors interpret as reactivating age-silenced genes 234. No study verified here shows a direct effect on prostate tissue or urinary symptoms in people.

What research shows

  • Cell study (lymphocytes from donors aged 75–88, 2004): Prostamax activated ribosomal genes and decondensed pericentromeric heterochromatin on chromosome 1 2.
  • Cell studies (human lymphocytes, 2004 and 2012): KEDP induced 'deheterochromatinization' (unpacking) of chromatin in cells from old individuals 43.
  • No controlled human trial of Prostamax for prostate enlargement or prostatitis was verified in this review.
  • Research comes almost entirely from the Khavinson group and its collaborators.

Doses studied in people

No verified dose from a published controlled human trial; doses circulating online are not trial-derived.

Read this first: these are the amounts given to participants in published studies or written on official prescribing labels, reported for reference. They are not recommendations. Trial doses were chosen for specific patients under medical supervision, and a dose that is safe in one person can be harmful in another.

Vial math

Many research vials hold 5 or 10 mg of powder. This table shows how much ends up in each mark on a U-100 insulin syringe for common amounts of added liquid. It is arithmetic only, not a dose.

VialLiquid addedConcentrationPer unit (0.01 mL)
5 mg1 mL5 mg/mL50 mcgOpen in calculator
5 mg2 mL2.5 mg/mL25 mcgOpen in calculator
5 mg3 mL1.67 mg/mL16.7 mcgOpen in calculator
10 mg1 mL10 mg/mL100 mcgOpen in calculator
10 mg2 mL5 mg/mL50 mcgOpen in calculator
10 mg3 mL3.33 mg/mL33.3 mcgOpen in calculator

More sizes: all vial sizes · How this works: Syringes and units · Reconstitution guide.

Safety

  • No formal human safety studies have been published; long-term safety is unknown.
  • FDA noted that injectable unapproved products like those in its 2026 warning letter pose particular public-health risks 5.
  • Unregulated 'research' products may vary in purity, sequence and content.

Report side effects of any drug or product to the FDA through MedWatch. For a possible poisoning in the US, call Poison Control at 1-800-222-1222.

History

Developed at the St. Petersburg Institute of Bioregulation and Gerontology; the institute's own material lists it among five synthetic peptides it says were adopted by the Russian Ministry of Health, a claim not independently verified 6. Chromatin studies were published in 2004–2012 234. On June 17, 2026, FDA issued a warning letter to the US seller Wholesale Peptide over Prostamax and Gonadorelin 5.

Common questions

Is Prostamax approved for enlarged prostate (BPH)?

No. In a June 2026 warning letter, FDA called Prostamax sold with BPH and bladder-control claims an unapproved new drug 5.

What does the research show?

Mostly lab studies showing chromatin changes in blood cells from elderly people 23. No controlled human trials for prostate conditions were verified.

Is Prostamax banned in sport?

It is not named on WADA's 2026 list, but non-approved substances generally fall under S0, prohibited at all times 8.

What are the known risks?

Human safety has not been formally studied. FDA has flagged injectable unapproved peptide products as a particular public-health risk 5.

Related compounds

Sources

  1. Khavinson VKh. Peptides, genome, aging. Advances in Gerontology 2014;4(4):337–345 (developer's review; Table 1 lists names, sequences and masses) Journal
  2. Khavinson VKh, Lezhava TA, Malinin VV. Effects of short peptides on lymphocyte chromatin in senile subjects. Bull Exp Biol Med 2004;137(1):78–81 Journal
  3. [Deheterochromatinization of the chromatin in old age induced by oligopeptide bioregulator (Lys-Glu-Asp-Pro)] (2012) Journal
  4. [The influence of the peptide bioregulator prostamax on heterochromatin of human lymphocytes in situ] (2004) Journal
  5. FDA Warning Letter to Wholesale Peptide (MARCS-CMS 729447), June 17, 2026 – names Prostamax and Gonadorelin as unapproved new drugs Regulatory
  6. St. Petersburg Institute of Bioregulation and Gerontology – institute overview (developer's own material, c. 2007) Regulatory
  7. FDA: Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (updated May 14, 2026) Regulatory
  8. WADA 2026 Prohibited List (official English text, Dutch Treaty Series Trb. 2026, 25) Regulatory

Last reviewed 2026-10-26 · How we research · Found an error? See our corrections policy.